LI Gen, MBA
VP, CCB Principal asset management
Areas of expertise: IVD, Orthopedics Implant Medical Devices, Medical Imaging Equipment, Minimally Invasive Surgical Instruments
Gen received an MBA in finance from Bryant University in Rhode Island. He’s been responsible for legal finance and medical industry investment at King & Wood Mallesons, CreditEase Wealth, CCB International and participated in more than 50 projects. He’s also been responsible for Oxford Nanopore (ONT), pioneering Pharmaceutical (HK9939) and Fanzhi Medical, Jiadong Health, Wulian Medical and other investment management work for more than 10 precision medicine, biomedicine and innovative medical device projects with a total management amount of more than 20 billion RMB.